Cardiovascular Disease Doctors in Kalamazoo, MI Accepting Medicare

30 Cardiovascular Disease doctors found. Showing 21 - 30

Dr. Robert A Williams, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Ste 100, Kalamazoo, MI 49007 Phone: 269-373-1592    Fax: 269-373-6270

Dr. Robert John Lapenna, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1717 Shaffer St, Suite 232, Kalamazoo, MI 49048 Phone: 269-226-5050    Fax: 269-226-5034

Dr. William Bernard Campbell, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1717 Shaffer St, Suite 232, Kalamazoo, MI 49048 Phone: 269-226-5050    Fax: 269-226-5034

Frank Chia-hong Chen, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1722 Shaffer St, Suite 1, Kalamazoo, MI 49048 Phone: 269-381-3963    Fax: 269-381-2809

Dr. Vishal Gupta, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1717 Shaffer St, Suite 232, Kalamazoo, MI 49048 Phone: 269-226-5050    Fax: 269-226-5034

Brett J Eliuk, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Suite 100, Kalamazoo, MI 49007 Phone: 269-373-1222    Fax: 269-373-6270

Dr. Douglas J Wunderly, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Ste 100, Kalamazoo, MI 49007 Phone: 269-373-1592    Fax: 269-373-6270

Dr. Min Luo, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1717 Shaffer St, Kalamazoo, MI 49048 Phone: 269-226-5050    Fax: 269-226-5034

Dr. Thomas A Keller Jr., M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Suite 100, Kalamazoo, MI 49007 Phone: 269-373-1222    Fax: 269-373-6270

John G Gustafson, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1722 Shaffer St, Suite 1, Kalamazoo, MI 49048 Phone: 269-381-3963    Fax: 269-381-2809

News Archive

Negative effects of global health initiatives on developing countries' health systems exaggerated, review shows

"An evaluation of the scientific evidence on the effects of global health initiatives on the health systems of developing countries concludes that the harmful effects have been exaggerated," according to a press release from the Royal Society of Medicine.

Imiquimod and PDT equivalent for superficial basal cell carcinoma

Imiquimod cream and photodynamic therapy for superficial basal cell carcinoma result in near equivalent rates of tumor-free survival after 1 year of treatment, a review shows.

School program to help children continue normal educational activities during treatment

Treatment for cancer and other catastrophic disease can last months or years and often makes it impossible for young patients to keep up with their local school curriculum. Teachers in the St. Jude School Program Presented by Target help patients continue their normal educational activities while away from their local schools. They are also part of the health care team that provides opportunities to continue normal educational activities through homebound or hospital-bound educational services. In addition, the team provides school re-entry services to ease the transition back to the community school.

Sientra's breast implant approved by the U.S. FDA

The implant, manufactured by Santa Barbara-based Sientra, can be used for breast tissue reconstruction for women of any age and for breast augmentation in women 22 or older. The approval resulted from three years of clinical studies on almost 1,800 patients. Tightening of the area around the implant, re-operation, implant removal, uneven appearance and infection were some of the complications experienced during the study. Sientra is required to continue studies on the implant's long-term safety, effectiveness and risks of rare diseases under the approval.

Read more Medical News

› Verified 9 days ago

• 1
• 2(current)